Ads
related to: klebsiella oxytoca treatment uti- Dosing and Administration
Access Info About Dosing and
Administration Here.
- Read FAQs
See Frequently Asked Questions
for a Treatment Option.
- Adverse Reactions
Find Adverse Reactions and
Important Safety Information Here.
- Susceptibility Info
Find More Information About
Susceptibility Testing Here.
- cUTIs Clinical Efficacy
View Info About Clinical Efficacy
Against Complicated UTIs.
- Professional Resources
Find Downloadable Resources
at the Official HCP Site.
- Dosing and Administration
Search results
Results From The WOW.Com Content Network
Klebsiella oxytoca on agar plate Klebsiella oxytoca is a Gram-negative , rod-shaped bacterium that is closely related to K. pneumoniae , from which it is distinguished by being indole-positive; it also has slightly different growth characteristics in that it is able to grow on melezitose , but not 3-hydroxybutyrate .
Klebsiella organisms can lead to a wide range of disease states, notably pneumonia, urinary tract infections, sepsis, meningitis, diarrhea, peritonitis and soft tissue infections. [6] [11] Klebsiella species have also been implicated in the pathogenesis of ankylosing spondylitis and other spondyloarthropathies. [12]
In a surveillance study between 1986 and 1989, P. aeruginosa was the third leading cause of all nosocomial infections, and specifically the number one leading cause of hospital-acquired pneumonia and third leading cause of hospital-acquired UTI. [3] Treatment of such infections can be difficult due to multiple antibiotic resistance, [4] and in ...
Carbapenem-resistant Enterobacteriaceae (CRE) have been defined as carbapenem-nonsusceptible and extended-spectrum cephalosporin-resistant Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae complex, Klebsiella pneumoniae, or Klebsiella oxytoca. Some exclude ertapenem resistance from the definition.
The genus Klebsiella was named after the German microbiologist Edwin Klebs (1834–1913). [citation needed] It is also known as Friedlander's bacillum in honor of Carl Friedländer, a German pathologist, who proposed that this bacterium was the etiological factor for the pneumonia seen especially in immunocompromised individuals such as people with chronic diseases or alcoholics.
TMP/SMX is commonly used due to its ability to achieve high concentrations in urinary tract tissues and urine. This antibiotic combination demonstrates notable efficacy in both the treatment and prophylaxis of recurrent urinary tract infections. [12] Common adverse effects include nausea, vomiting, rash,pruritus, and photosensitivity. [26]